Utah Medical Products Interest Expense 2011-2026 | UTMD

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Utah Medical Products

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
256 K	188 K	-	-	-8 K	437 K	-32 K	132 K	65 K	289 K	438 K	652 K	859 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
859 K	-32 K	298 K

Quarterly Interest Expense Utah Medical Products

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
698 K	640 K	705 K	-	836 K	773 K	915 K	-	812 K	747 K	680 K	-	198 K	142 K	8 K	-	59 K	60 K	10 K	-	1 K	-	125 K	-	76 K	84 K	36 K	-	79 K	500 K	37 K	-	17 K	23 K	26 K	-	41 K	64 K	101 K	-	127 K	-43 K	-210 K	-	-107 K	-132 K	-61 K	-	-88 K	-89 K	-102 K	-	-111 K	-122 K	-178 K	-	-265 K	-281 K	-15 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
915 K	-281 K	155 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
Baxter International BAX	408 M	$ 19.93	0.99 %	$ 10.2 B	USA
Ekso Bionics Holdings EKSO	-1 K	$ 8.71	3.75 %	$ 176 M	USA
Alcon ALC	192 M	$ 81.19	0.07 %	$ 40.4 B	Schweiz
AtriCure ATRC	-326 K	$ 36.37	-1.57 %	$ 1.71 B	USA
Repro Med Systems KRMD	561 K	$ 5.37	-1.56 %	$ 245 M	USA
Haemonetics Corporation HAE	-9.75 M	$ 65.87	-0.15 %	$ 3.32 B	USA
electroCore ECOR	6.3 M	$ 6.83	-3.73 %	$ 37.7 K	USA
AngioDynamics ANGO	4.94 M	$ 10.2	2.2 %	$ 417 M	USA
ICU Medical ICUI	107 M	$ 149.04	-0.66 %	$ 3.63 B	USA
InfuSystem Holdings INFU	1.4 M	$ 8.14	1.12 %	$ 168 M	USA
The Cooper Companies COO	-16.4 M	$ 80.95	0.72 %	$ 16.1 B	USA
Masimo Corporation MASI	300 K	$ 134.5	-1.29 %	$ 7.17 B	USA
Harvard Bioscience HBIO	-227 K	$ 0.5	-7.06 %	$ 21.2 M	USA
Glaukos Corporation GKOS	13.6 M	$ 117.26	-1.43 %	$ 5.68 B	USA
Merit Medical Systems MMSI	-711 K	$ 80.09	-0.19 %	$ 4.66 B	USA
OraSure Technologies OSUR	-380 K	$ 2.78	-0.54 %	$ 207 M	USA
Isoray ISR	2 K	-	0.03 %	$ 108 M	USA
iRhythm Technologies IRTC	1.25 M	$ 150.09	0.74 %	$ 4.68 B	USA
LeMaitre Vascular LMAT	205 K	$ 84.08	0.26 %	$ 1.89 B	USA
STERIS plc STE	8.4 M	$ 261.25	-0.23 %	$ 25.8 B	USA
Microbot Medical MBOT	2 K	$ 1.84	-1.34 %	$ 18.8 M	Israel
Nephros NEPH	2 K	$ 4.4	0.23 %	$ 45.7 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.29	-0.7 %	$ 23.1 M	USA
Envista Holdings Corporation NVST	-100 K	$ 23.07	-1.28 %	$ 3.97 B	USA
Pro-Dex PDEX	533 K	$ 38.84	-1.43 %	$ 128 M	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
Pulse Biosciences PLSE	983 K	$ 13.69	0.48 %	$ 658 M	USA
Becton, Dickinson and Company BDX	613 M	$ 201.67	0.29 %	$ 58 B	USA
Repligen Corporation RGEN	8.12 M	$ 151.86	-2.88 %	$ 8.46 M	USA
ResMed RMD	3.2 M	$ 251.52	-2.37 %	$ 36.7 B	USA
BioLife Solutions BLFS	497 K	$ 22.08	-2.21 %	$ 1.02 B	USA
Stereotaxis STXS	1.1 M	$ 2.26	-3.21 %	$ 182 M	USA
Retractable Technologies RVP	227 K	$ 0.69	0.16 %	$ 20.7 M	USA
STAAR Surgical Company STAA	815 K	$ 18.79	-0.8 %	$ 923 M	USA
Teleflex Incorporated TFX	57 M	$ 105.0	-0.43 %	$ 4.92 B	USA
West Pharmaceutical Services WST	-1 M	$ 226.43	-2.61 %	$ 16.5 B	USA
DENTSPLY SIRONA XRAY	12 M	$ 12.28	0.04 %	$ 2.5 B	USA